Atheroprotective natural anti-phosphorylcholine antibodies of IgM subclass are decreased in Swedish controls as compared to non-westernized individuals from New Guinea

Overview of attention for article published in Nutrition & Metabolism, January 2007

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)

Mentioned by

twitter: 2 tweeters
patent: 5 patents

facebook: 2 Facebook pages

Citations

dimensions_citation: 42 Dimensions

Readers on

mendeley: 28 Mendeley

Summary Twitter Patents Facebook Dimensions citations

So far, Altmetric has seen 5 patents that reference this research output.

ANTIBODIES FOR USE IN COMBINATION THERAPY

Application WO-2019215300-A1

World Intellectual Property Organisation (WIPO)

LIPID-RELATED ANTIGENS AND ANTIBODIES DIRECTED AGAINST THEM

Application WO-2018220224-A1

World Intellectual Property Organisation (WIPO)

PHOSPHORYLCHOLINE OR PHOSPHORYLCHOLINE CONJUGATE IN COMBINATION THERAPY WITH BIOLOGIC…

Application EP-3176179-A1

European Patent Office

DIAGNOSTIC AND THERAPEUTIC METHODS AND COMPOSITIONS FOR METABOLIC DISEASE

Application WO-2012010291-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 1 additional patents.